FLU Clinical Trial
Official title:
A Phase II, Observer-Blind, Parallel Groups, Single Center, Extension Study to Evaluate the Immunogenicity and Safety Following a Single Intramuscular Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine in the Previous V70P2 Study.
The purpose of this research is to evaluate the immunogenicity of a single dose of Influenza Vaccines (0.5mL or 0.25mL) in healthy children aged up to 35 months or 36 up to 48 months. To evaluate the safety and tolerability of a single 0.25mL IM of injection influenza vaccines in healthy children aged up to 35 months; to evaluate the safety and tolerability of a single 0.50mL IM injection of influenza vaccines in healthy children aged up to 48 months.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06057727 -
Behavioral Economics to Improve Flu Vaccination Using EHR Nudges
|
N/A | |
| Completed |
NCT03694808 -
FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care
|
Phase 4 | |
| Completed |
NCT06385821 -
A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus
|
Phase 3 | |
| Completed |
NCT01440205 -
Licensing Flu Shot Study
|
N/A | |
| Terminated |
NCT00769002 -
PET-CT Scans in Healthy Volunteers After Flu Vaccination
|
N/A | |
| Completed |
NCT03308825 -
Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines
|
Phase 4 | |
| Completed |
NCT03189537 -
Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections
|
Phase 3 | |
| Completed |
NCT01484522 -
Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth
|
N/A | |
| Completed |
NCT03344029 -
Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years
|
Phase 4 | |
| Completed |
NCT01459952 -
A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold
|
Phase 3 | |
| Recruiting |
NCT06158659 -
Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula
|
N/A | |
| Completed |
NCT05417997 -
Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
|
Phase 3 | |
| Completed |
NCT01389518 -
Efficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu Syndrome
|
Phase 3 | |
| Completed |
NCT02822105 -
Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers
|
Phase 1 | |
| Withdrawn |
NCT02037282 -
A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03293979 -
Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis
|
||
| Completed |
NCT04153331 -
Burden of Influenza at Emergency Department Level : BIED
|
N/A | |
| Not yet recruiting |
NCT05473325 -
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)
|
||
| Completed |
NCT01533220 -
Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal
|
Phase 3 | |
| Recruiting |
NCT04515446 -
Quantification of Viral Load in the Upper Respiratory Tract in Patients Treated With Olsetamivir for Influenza
|
N/A |